Dermal Cell News Volume 8.32 | Oct 24 2022

    0
    74








    2022-10-24 | DCN 8.32


    Dermal Cell News by STEMCELL Technologies
    TOP STORY
    Vol. 8.32 – 24 October, 2022

    IL-17D-Induced Inhibition of DDX5 Expression in Keratinocytes Amplifies IL-36R-Mediated Skin Inflammation

    Researchers found that the RNA helicase DDX5 was downregulated in keratinocytes from the inflammatory skin lesions in patients with atopic dermatitis and psoriasis, and that mice with keratinocyte-specific deletion of Ddx5 were more susceptible to cutaneous inflammation.
    [Nature Immunology]

    Full Article
    Activate, expand, and differentiate your cells with cytokines, chemokines, and growth factors from STEMCELL Technologies.
    PUBLICATIONSRanked by the impact factor of the journal

    Sufu- and Spop-Mediated Regulation of Gli2 Is Essential for the Control of Mammalian Cochlear Hair Cell Differentiation

    Scientists demonstrated that restriction of Gli2 expression, the major transcriptional activator of the sonic hedgehog signaling pathway, was a prerequisite for cochlear hair cell differentiation.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Secretome of Human Umbilical Cord Mesenchymal Stem Cell Maintains Skin Homeostasis by Regulating Multiple Skin Physiological Function

    Researchers evaluated the therapeutic potential of the secretome of human umbilical cord mesenchymal stem cells for dermatological diseases in adult human skin cells, ex vivo skin tissue, and a 3D skin model.
    [Cell and Tissue Research]

    Abstract

    Nestin Is a Marker of Unipotent Embryonic and Adult Progenitors Differentiating into an Epithelial Cell Lineage of the Hair Follicles

    Scientists determined the exact stage when nestin-expressing outer root sheath stem/precursor cells or their descendants appeared during hair follicle morphogenesis, and whether they were present in adult hair follicles.
    [Scientific Reports]

    Full Article

    SRC-RAC1 Signaling Drives Drug Resistance to BRAF Inhibition in De-Differentiated Cutaneous Melanomas

    Investigators showed that wildtype RAC1 was a critical driver of growth and drug resistance, but only in a subset of melanomas with elevated markers of de-differentiation. Similarly, SRC inhibition also selectively sensitized de-differentiated melanomas to BRAF inhibition.
    [npj Precision Oncology]

    Full Article

    Epithelial–Mesenchymal Transition Inhibition by Metformin Reduces Melanoma Lung Metastasis in a Murine Model

    Researchers investigated the effects of metformin at epithelial-mesenchymal transition (EMT) in melanoma cell lines B16-F10 and A-375, in vitro, and the impact of EMT downregulation on melanoma progression in vivo.
    [Scientific Reports]

    Full Article
    Explore tools and resources for your return to the lab
    REVIEWS

    Neuro–Epithelial–ILC2 Crosstalk in Barrier Tissues

    The authors review how ILC2s integrate epithelial signals and neurogenic components to preserve the tissue microenvironment and modulate inflammation, highlighting recent findings suggesting neuro-epithelial-ILC2 crosstalk.
    [Trends in Immunology]

    Abstract

    Skin Cell-Derived Extracellular Vesicles: A Promising Therapeutic Strategy for Cutaneous Injury

    Scientists describe the characteristics of wound healing, concentrating on the production and functions of extracellular vesicles (EVs) derived from specific skin cells, and provide new ideas for wound therapy using EVs.
    [Burns & Trauma]

    Full Article
    INDUSTRY AND POLICY NEWS

    Dozens of Papers Co-Authored by Nobel Laureate Raise Concerns

    Concerns about image integrity have so far led to 17 retractions, corrections or expressions of concern for papers co-authored by geneticist Gregg Semenza. [Nature News]

    Press Release
    FEATURED EVENT

    Frontiers in Cancer Science 2022

    November 7 – 9, 2022
    Singapore, Singapore

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Tissue Injury and Repair

    The University of British Columbia – Vancouver, British Columbia, Canada

    Senior Bioinformaticians – Skin Cancer Research

    Wellcome Genome Campus – Saffron Walden, United Kingdom

    Clinical Trial Educator – Melanoma

    IQVIA – Toronto, Ontario, Canada

    Associate Professor – Skin Cancer

    University College Dublin – Dublin, Ireland

    Clinical Director – Department of Health and Human Services

    NCI – Bethesda, Maryland, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Dermal Cell News Twitter